These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 1657912
1. Effects of a novel lanosterol 14 alpha-demethylase inhibitor on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in Hep G2 cells. Mayer RJ, Adams JL, Bossard MJ, Berkhout TA. J Biol Chem; 1991 Oct 25; 266(30):20070-8. PubMed ID: 1657912 [Abstract] [Full Text] [Related]
2. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity. Boogaard A, Griffioen M, Cohen LH. Biochem J; 1987 Jan 15; 241(2):345-51. PubMed ID: 3036060 [Abstract] [Full Text] [Related]
3. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol. Iglesias J, Gibbons GF. Biochem J; 1989 Dec 01; 264(2):495-502. PubMed ID: 2604729 [Abstract] [Full Text] [Related]
4. Lanosterol analogs: dual-action inhibitors of cholesterol biosynthesis. Frye LL, Leonard DA. Crit Rev Biochem Mol Biol; 1999 Dec 01; 34(2):123-40. PubMed ID: 10333389 [Abstract] [Full Text] [Related]
5. Oxolanosterol oximes: dual-action inhibitors of cholesterol biosynthesis. Frye LL, Cusack KP, Leonard DA, Anderson JA. J Lipid Res; 1994 Aug 01; 35(8):1333-44. PubMed ID: 7989858 [Abstract] [Full Text] [Related]
6. Effects of 19-oxygenated lanosterol derivatives on 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and lanosterol demethylase activity. Sonoda Y, Suzuki S, Udagawa K, Ota K, Tasaka R, Fukamachi Y, Sato Y. Biol Pharm Bull; 1996 Jan 01; 19(1):57-61. PubMed ID: 8820912 [Abstract] [Full Text] [Related]
7. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis. Trzaskos JM, Magolda RL, Favata MF, Fischer RT, Johnson PR, Chen HW, Ko SS, Leonard DA, Gaylor JL. J Biol Chem; 1993 Oct 25; 268(30):22591-9. PubMed ID: 7693673 [Abstract] [Full Text] [Related]
8. Modulation of regulatory oxysterol formation and low density lipoprotein suppression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity by ketoconazole. A role for cytochrome P-450 in the regulation of HMG-CoA reductase in rat intestinal epithelial cells. Gupta A, Sexton RC, Rudney H. J Biol Chem; 1986 Jun 25; 261(18):8348-56. PubMed ID: 3722155 [Abstract] [Full Text] [Related]
9. The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Berkhout TA, Simon HM, Patel DD, Bentzen C, Niesor E, Jackson B, Suckling KE. J Biol Chem; 1996 Jun 14; 271(24):14376-82. PubMed ID: 8662919 [Abstract] [Full Text] [Related]
11. Regulation of squalene synthetase in human hepatoma cell line Hep G2 by sterols, and not by mevalonate-derived non-sterols. Cohen LH, van Miert E, Griffioen M. Biochim Biophys Acta; 1989 Mar 14; 1002(1):69-73. PubMed ID: 2538145 [Abstract] [Full Text] [Related]
12. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols. Cenedella RJ. Exp Eye Res; 1997 Jul 14; 65(1):63-72. PubMed ID: 9237866 [Abstract] [Full Text] [Related]
13. 15-substituted lanosterols: post-transcriptional suppressors of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Anderson JA, Leonard DA, Cusack KP, Frye LL. Arch Biochem Biophys; 1995 Jan 10; 316(1):190-6. PubMed ID: 7840615 [Abstract] [Full Text] [Related]
14. Effect of a novel squalene epoxidase inhibitor, NB-598, on the regulation of cholesterol metabolism in Hep G2 cells. Hidaka Y, Hotta H, Nagata Y, Iwasawa Y, Horie M, Kamei T. J Biol Chem; 1991 Jul 15; 266(20):13171-7. PubMed ID: 1649182 [Abstract] [Full Text] [Related]
15. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity. Burton PM, Swinney DC, Heller R, Dunlap B, Chiou M, Malonzo E, Haller J, Walker KA, Salari A, Murakami S. Biochem Pharmacol; 1995 Aug 08; 50(4):529-44. PubMed ID: 7646560 [Abstract] [Full Text] [Related]
16. In situ accumulation of 3 beta-hydroxylanost-8-en-32-aldehyde in hepatocyte cultures. A putative regulator of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity. Trzaskos JM, Favata MF, Fischer RT, Stam SH. J Biol Chem; 1987 Sep 05; 262(25):12261-8. PubMed ID: 3624256 [Abstract] [Full Text] [Related]
17. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 3 beta-hydroxy-lanost-8-en-32-al, an intermediate in the conversion of lanosterol to cholesterol. Leonard DA, Kotarski MA, Tessiatore JE, Favata MF, Trzaskos JM. Arch Biochem Biophys; 1994 Apr 05; 310(1):152-7. PubMed ID: 8161198 [Abstract] [Full Text] [Related]
18. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase. Cohen LH, van Vliet A, Roodenburg L, Jansen LM, Griffioen M. Biochem Pharmacol; 1993 Jun 09; 45(11):2203-8. PubMed ID: 8517861 [Abstract] [Full Text] [Related]
19. Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJ. J Biol Chem; 1993 May 25; 268(15):11230-8. PubMed ID: 8388388 [Abstract] [Full Text] [Related]
20. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2. Cohen LH, Griffioen M, Havekes L, Schouten D, van Hinsbergh V, Kempen HJ. Biochem J; 1984 Aug 15; 222(1):35-9. PubMed ID: 6089762 [Abstract] [Full Text] [Related] Page: [Next] [New Search]